DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Patient-Centered Care and Asian Americans

Information source: University of California, San Francisco
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hepatitis B; Hepatitis C; Liver Disease

Intervention: Video Doctor, PA + PPN (Behavioral)

Phase: N/A

Status: Active, not recruiting

Sponsored by: University of California, San Francisco

Official(s) and/or principal investigator(s):
Tung Nguyen, MD, Principal Investigator, Affiliation: University of California, San Francisco

Summary

Liver cancer and hepatitis B are major health disparities for Asian Americans, while hepatitis C is a rising problem. Little is known about how to improve the quality of health care Asian Americans receive in general and for viral hepatitis in particular. Technology, specifically mobile applications, potentially can provide a flexible and efficient way to address these challenges. This proposed project seeks to develop, implement, and test an intervention to increase hepatitis B and C screening for Asian Americans in 2 healthcare systems in the San Francisco Bay Area. The research team will develop, implement, and evaluate the efficacy of an interactive, patient- centered mobile application for use on a tablet computer to increase the rate of hepatitis B and C screening among unscreened Asian Americans age 18 and older. The team will use their experience from a successful track record in health promotion to develop the intervention by working with patients, community leaders and advocates, clinical staff, healthcare providers, and healthcare system administrators from a county safety net system and an academic primary care practice in the San Francisco Bay Area. The mobile application will include video clips with a physician (Video Doctor) addressing patient concerns regarding hepatitis B and C screening in the patient's preferred language, English, Chinese, or Vietnamese. A patient who has not been screened for hepatitis B will answer questions about his or her characteristics and preferences using the mobile application. The mobile application will then show 30-60 seconds video clips with messages that address the patient's responses related to hepatitis B screening and that are delivered by an actor playing a physician. Those who are born between 1945 and 1965 also receive messages about hepatitis C screening. At the end, the tablet computer will generate a provider alert to let the treating provider know what the patient's preferences are regarding testing for viral hepatitis. Once developed, the intervention will then be used in combination with a physician panel notification and tested against physician panel notification only in a randomized controlled trial to see which approach is better in increasing the rate of hepatitis B and C screening. The team will also work with the 2 healthcare system to ensure that the interventions will be practical and easily adopted once the study is over. The findings of this project will greatly expand understanding about how to use technology- based interventions to improve quality of healthcare in diverse patient populations.

Clinical Details

Official title: A Patient-Centered Intervention to Increase Screening of Hepatitis B and C Among Asian Americans

Study design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Screening

Primary outcome: EHR-documented hepatitis B surface antigen (HBsAg) test

Secondary outcome: Knowledge about hepatitis B virus (HBV) and hepatitis C virus (HCV)

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- ages 18+ years

- identifies as Asian

- Asian American, Chinese, or Vietnamese

- speaks English, Chinese (Cantonese), or Vietnamese

- does not have an electronic health record (EHR)-documented HBV screening test

(defined as a hepatitis B surface antigen [HBsAg] test).

- we select Chinese and Vietnamese because those are the 2 most common languages spoken

by limited English-proficient Asian Americans Exclusion Criteria:

- dementia or any conditions precluding understanding informed consent or using a touch

screen with audio

Locations and Contacts

San Francisco General Hospital, San Francisco, California 94110, United States

UCSF, San Francisco, California 94143, United States

Additional Information

Starting date: September 2013
Last updated: May 13, 2014

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017